Dealstreet

JSA advises Somerset Indus Capital Partners on Apex Hospitals exit

The transaction involved life sciences-focused private equity firm InvAscent acquiring a significant stake in Apex Hospitals via primary and secondary funding.

Bar & Bench

JSA advised Somerset Indus Capital Partners on its exit from Apex Hospitals, a leading multi-specialty hospital chain in Rajasthan.

The transaction involved life sciences-focused private equity firm InvAscent acquiring a significant stake in Apex Hospitals via primary and secondary funding.

The JSA team comprised Siddharth Mody (Lead Partner), Rohan Kumar (Partner), and Niharika Rao (Senior Associate).

InvAscent, through its India Life Sciences Fund IV, invested approximately USD 30 million (₹265 crore), enabling the acquisition of Somerset’s stake and providing fresh growth capital. Somerset achieved a complete exit from its May 2019 investment, reportedly realizing a 4x return on invested capital.

During Somerset’s holding period, Apex Hospitals is said to have tripled its revenue and recorded a four-fold increase in EBITDA. Post-transaction, Apex Hospitals’ promoters will retain majority ownership and continue to lead operations, while the new capital infusion will support expansion into western and northern India.

Khaitan, TT&A act on L Catterton's investment in Haldiram

CAM advises Zenrock Chemicals and EAAA India on acquiring promoter stake in Indo Borax & Chemicals

Former Bharucha Partner Parag Bhide joins AQUILAW to head Corporate and M&A practice in Mumbai

Luthra advises Protean on stake acquisition in NSDL Payments Bank

IndiGo: Crisis, compliance and consumer impact

SCROLL FOR NEXT